Senior Analyst, Drug Development & Clinical Strategy

Role: Senior Analyst supporting strategic decision-making in drug development pipeline through analytics and market intelligence. Objectives: identify high-value, tractable opportunities across disease areas, inform indications, patient segments, and development paths. Responsibilities: analyze markets, industry landscape, and customer needs across therapeutic areas; conduct market sizing, competitive analysis, and validate insights via external expert engagement; collaborate with clinical, drug development, finance, and business teams to develop valuation models and forecasts; design data models, analytical frameworks, dashboards, and scenario tools; prototype and deploy AI-enabled analytical solutions; support internal planning and target-setting. Requirements: Bachelor's in health sciences or related field; 3+ years in pharma/biotech with product planning, commercial strategy, or related experience; familiarity with disease segments such as cardiovascular, renal, metabolic, oncology, or autoimmune; knowledge of drug development strategies, regulatory pathways, healthcare databases, and valuation methods; strong analytical, research, and communication skills. Preferred: advanced degree (MD, PhD), 4-6+ years industry experience, genomic-based drug discovery knowledge. HighValue: early-stage biotech, genetics focus, cross-functional collaboration, market and commercial analytics, supporting pipeline prioritization and strategic planning. WorkSetup: flexible UK or US-based office; no specific travel requirements mentioned.